Next Article in Journal
Evaluation of the One Health-Ness of 20 Years of Antimicrobial Resistance Surveillance in Norway
Next Article in Special Issue
A Novel Bacitracin-like Peptide from Mangrove-Isolated Bacillus paralicheniformis NNS4-3 against MRSA and Its Genomic Insights
Previous Article in Journal
The Use of Phage Cocktail and Various Antibacterial Agents in Combination to Prevent the Emergence of Phage Resistance
Previous Article in Special Issue
Using Targeted Nano-Antibiotics to Improve Antibiotic Efficacy against Staphylococcus aureus Infections
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 12
Issue 6
10.3390/antibiotics12061079
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Epidemiology of Animal-Associated Methicillin-Resistant Staphylococcus aureus

by
Martyna Kasela
1,
Mateusz Ossowski
2,*,
Ewelina Dzikoń
3,
Katarzyna Ignatiuk
3,
Łukasz Wlazło
2 and
Anna Malm
1
1
Department of Pharmaceutical Microbiology, Medical University of Lublin, Chodzki Street 1, 20-093 Lublin, Poland
2
Department of Animal Hygiene and Environmental Hazards, University of Life Sciences in Lublin, Akademicka 13, 20-950 Lublin, Poland
3
Student’s Scientific Circle, Department of Pharmaceutical Microbiology, Medical University of Lublin, Chodzki Street 1, 20-093 Lublin, Poland
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(6), 1079; https://doi.org/10.3390/antibiotics12061079
Submission received: 30 May 2023 / Revised: 14 June 2023 / Accepted: 18 June 2023 / Published: 20 June 2023
(This article belongs to the Special Issue The Emergence of Drug-Resistant Staphylococcus aureus Infection and Recent Advances in Treatment Options)
Browse Figure
Versions Notes

Abstract

:
Methicillin-resistant Staphylococcus aureus (MRSA) remains an important etiological factor of human and animal infectious diseases, causing significant economic losses not only in human healthcare but also in the large-scale farming sector. The constantly changing epidemiology of MRSA observed globally affects animal welfare and raises concerns for public health. High MRSA colonization rates in livestock raise questions about the meaning of reservoirs and possible transmission pathways, while the prevalence of MRSA colonization and infection rates among companion animals vary and might affect human health in multiple ways. We present the main findings concerning the circulation of animal-associated MRSA (AA-MRSA) in the environment and factors influencing the direction, mechanisms, and routes of its transmission. Studies have shown it that S. aureus is a multi-host bacterial pathogen; however, its adaptation mechanisms enabling it to colonize and infect both animal and human hosts are still rarely discussed. Finally, we elaborate on the most successful strategies and programs applied limiting the circulation of AA-MRSA among animals and humans. Although MRSA strains colonizing animals rarely infect humans, they undergo host-adaptive evolution enabling them to spread and persist in human populations.

1. Introduction

Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), is not only one of the most common etiological factors of human infectious disease but also a pathogen with a profound impact on animal welfare because of increasing antibiotic resistance and the resulting economic burden [1,2]. The first reports concerning MRSA date back to the years 1959–1960, when it evolved from a susceptible S. aureus strain as a result of the implementation of methicillin as a new antimicrobial drug in hospitals. Additionally, the first observations suggested that it originated from one epidemic clone as all investigated strains exhibited the same antimicrobial resistance profile (penicillin, streptomycin, and tetracycline), [3]. Described by the Centers for Disease Control and Prevention as an note-threating microorganism quickly acquiring antibiotic resistance, MRSA gradually spread around the world, resulting in a high epidemiological burden both for humans as well as animals [4]. The strains are all characterized by the presence of an acquired type of resistance to β-lactam antibiotics encoded by genes from the mec group (mecA, mecB, and mecC) located in the staphylococcal chromosomal cassette (SCCmec). Genes encode for novel types of the penicillin-binding protein exhibiting decreased affinity to β-lactams resulting in inactivation of an antibiotic [5]. Depending on the setting, where the MRSA infection has been first reported, strains are divided into certain subpopulations. For human infections, the most prevalent hospital-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA) inform as to whether the strains were isolated in a nosocomial environment or outside, respectively. The third subpopulation—animal-associated MRSA (AA-MRSA), sometimes limited only to livestock-associated-MRSA (LA-MRSA)—includes pathogens isolated from animals [6,7]. The determination of subpopulation type can be helpful in epidemiological investigation by providing information about certain MRSA clone origins; however, the dynamic spread and transmission of MRSA worldwide blur the formerly clear line between clones of human and animal origin.
Since first MRSA was discovered, it has consequently gained resistance to other classes of antibiotics, like macrolides and tetracyclines, or chemotherapeutics, like fluoroquinolones, resulting in difficulties in the development of successful antimicrobial therapy in infected individuals [8]. While even more health-threatening S. aureus strains have emerged, including vancomycin-resistant S. aureus (VRSA) often characterized by multi-drug resistance, MRSA still remains the main therapeutic challenge worldwide [9]. Depending on the character and location of infection, routine antimicrobial therapy of MRSA infections consists of the application of several antimicrobial drugs, i.e., vancomycin in the case of MRSA bacteremia, daptomycin in the treatment of soft-tissue infections, or mupirocin for skin infections. For infections caused by multi-drug-resistant strains, novel antimicrobial agents are often applied, e.g., linezolid antibiotic, or multiple semisynthetic drugs, such as tigecycline, dalbavancin, oritavancin, iclaprim, cethromycin, or delafloxacin [10]. Except standard antibiotic therapy, alternative treatments and agents supporting antibiotic therapy are being developed as a new approach for the treatment of MRSA infections. The above-mentioned strategies consist of combining known antimicrobial agents with substances or compounds of natural origin or the application of a combination of two or more antimicrobial agents [8]. In spite of all these efforts, the emergence of resistance to new antimicrobials is being observed. MRSA strains resistant to daptomycin were described just years after the official Food and Drug Administration approval for the treatment of S. aureus in 2006. A similar situation has been noted for linezolid, implemented for treatment in the year 2000, to which resistance was first described in 2005. Since then, S. aureus has developed several resistance mechanisms [11].
The growing antibiotic resistance to so called “last resort” antibiotics in the treatment of serious bacterial infections drastically limits the current therapeutic options. There are several factors that increase the risk of acquiring antibiotic resistance in bacteria. They include: the excessive use of antimicrobial agents creating selective pressure enabling resistance to develop and persist in the environment, the emergence of novel sources of drug-resistant bacteria as well as novel routes for these bacteria to spread which allows not only the direct transmission of MRSA but also the occurrence of the horizontal transfer of resistance factors [12]. In the recent years, animals have become a profound secondary source of MRSA in the environment, and the frequent contact between animals and humans create a significant route of their transmission [13]. Therefore, to further fight antibiotic resistance in S. aureus, it is indispensable to investigate and understand novel reservoirs of antibiotic-resistant bacteria and the evolutionary consequences of their global spread. The epidemiology of MRSA is changing dynamically due to intensive circulation within the community and farming environment [14]. However, the transfer of microorganisms between humans and animals seems to be a part of the natural process of microbial adaptation. The interspecies transmission of antibiotic-resistant bacteria raises significant concerns for public health. The prevalence and risk factors for colonization and subsequent infection with multidrug-resistant microbes among humans are well established when compared with animal populations [15]. MRSA colonizes and infects companion animals and wild animals as well as livestock, causing serious diseases of worldwide significance, e.g., in poultry or dairy cows [16].
In the present day, routine epidemiological investigation of MRSA includes the application of a variety of genotyping techniques, enabling interfacility results comparison. The most prevalently used multi-locus sequence typing (MLST) provides information about the clonal complexes (CC) and sequence types (ST) of MRSA circulating in the environment. A steady decrease in the costs of whole genome sequencing (WGS) and the development of techniques enabling high-throughput analysis have resulted in novel research in the field of microbial transmission [17]. Recent findings concerning the spread of MRSA in the environment provide valuable data useful in the development of control strategies and successful measures significantly limiting AA-MRSA transmission.
In spite of multiple advancements in the treatment of bacterial infections, multi-drug-resistant strains of S. aureus undeniably remain one of the major pathogens in animals and humans. This review not only summarizes crucial information concerning the most important characteristics of AA-MRSA but also points out the main findings about its spread in the environment and the possibility and mechanisms of its transmission between various hosts, taking into account the interconnection between animals and humans. Finally, this review is aimed at discussing the most successful strategies applied to limit the circulation of MRSA in the animal farming environment, creating simple guidelines and presenting general recommendations.

2. Methicillin-Resistant Staphylococcus aureus in Companion Animals

Companion animals might be a significant reservoir of MRSA circulating in the environment. The presence of multi-drug-resistant bacterial strains in households poses a threat not just to human and animal health but especially for people who are immunocompromised because of various medical conditions as well as those undergoing immunosuppressive treatment. Therefore, epidemiological investigations on MRSA colonization rates in companion animals provide valuable data on the scale of the problem.
Studies have shown that the nares, mouth, and perineum are the major colonization sites in cats and dogs; however, the persistence of carriage itself remains poorly investigated [18]. Both animals and owners can be colonized by S. aureus as an effect of indirect everyday interaction with each other as well as contact with contaminated surfaces within the household [19,20]. Multiple studies have detected the presence of MRSA in not only pets, mainly dogs and cats [21,22,23,24,25,26,27,28,29], but also other companion species like birds, guinea pigs, turtles [30], or hamsters [31]. This wide dissemination proves that MRSA is well adapted to colonize a wide spectrum of animal hosts.
The methicillin-resistant S. aureus colonization rates given by multiple studies are highly diversified and depend on various factors, including geographical location, the animal population studied, household hygienic conditions, and many others. Recent studies have shown alarmingly high MRSA colonization rates in most common species of companion animals—dogs and cats. Moreover, taking into consideration the number of cats and dogs kept as companion animals worldwide, the scale at which transmission between pets and the owners might occur is disturbing. In the study conducted by Strommenger et al. in Germany, all S. aureus strains isolated from pet dogs and cats harbored the mecA gene [32]. Similarly, relatively high MRSA colonization rates were observed in France, where MRSA colonized 39.3% of dogs, 26.5% of cats, and as high as 47.1% of horses [25]. Also, Drougka et al., whose study was located in Greece, investigated the prevalence of S. aureus among companion dogs and cats and found 37% and 30% methicillin-susceptible S. aureus (MSSA) isolation rates, respectively, while the overall MRSA prevalence rate accounted for 10.8% [33]. The prevalence of certain clonal lineages of MRSA isolated from companion animals remains similar within European countries and, according to the authors, often reflects dominating lineages of MRSA of human origin (Table 1). In contrast to dogs and cats, only horses are usually colonized by MRSA strains typical for livestock, e.g., in France, as many as 72.1% of MRSA strains isolated from horses belonged to CC398 [25].
Fewer researchers have focused on the possibility of interspecies transmission between pets and their owners and conducted studies with the use of genotyping methods [22]. Researchers suggest that transmission from humans to companion animals occurs more prevalently due to overlapping of their habitats [46]. Moreover, multiple studies have proven that humans are the main source of the MRSA colonizing companion animals, which would explain the high colonization rates in cats and dogs maintaining close contact with owners and living in an area of limited space. These animals might become a profound secondary source for human and animal infections, which is emphasized by the fact that strains of human origin, especially HA-MRSA, often carry more antibiotic-resistance and virulence genes than strains of animal origin [25]. The reports of typical nosocomial MRSA strains’ isolation from dogs and cats (e.g., ST5, ST45, and ST239) prove that pets might act as a secondary reservoir for virulent S. aureus strains in the environment [22]. The enhanced virulence of MRSA is often connected with the production of specific toxins resulting in more severe disease symptoms in the case of infection. The production of Panton–Valentine leucocidin toxin, strongly associated with skin and soft-tissue infections and tissue necrosis in community-acquired pneumonia, might have serious health implications not only for immunocompromised people but also for young and healthy individuals [47]. The high isolation rates of pvl-positive S. aureus strains from healthy dogs and cats in certain European regions, ranging from 25% to even 87.5%, underlining the need for epidemiological monitoring of MRSA colonizing pet animals, especially in the context of pet owners predisposed to community-acquired staphylococcal infections [24,33,48].
The main concern about S. aureus transmission between humans and animals is the spread of zoonotic diseases in the general population; nevertheless, a recent study conducted by Bierowiec et al. proved that close contact with owners predisposed companion cats to significantly higher S. aureus colonization rates than free-living, domestic cats. Moreover, the prevalence of MRSA was also found to be higher among pet cats, which confirms the assumed direction of MRSA transmission from owners to companion animals [21]. Other factors recently discovered to be significantly associated with the S. aureus colonization of both dogs and cats are the young age of the animals (<12 mo.), living in rural areas, possessing skin diseases at the time of swab collection, and simultaneous colonization with coagulase-negative staphylococci [33].
Recent studies clearly show the growing importance of companion animals as a secondary reservoir of drug-resistant pathogens in the environment. Human infections caused by MRSA isolated simultaneously from companion animals occur rarely; however, researchers emphasize the role of proper hygienic conditions in households in limiting the risk of colonization and subsequent infection in pet owners [23,31].

3. Methicillin-Resistant Staphylococcus aureus in Livestock Animals

The human population is steadily expanding into new geographical areas, which together with the increase in the number of large-scale animal farms generates new transmission pathways that ease the spread of MRSA in the environment. High MRSA colonization rates in livestock farming environments and the emergence of LA-MRSA in humans raise questions regarding its origin and possible transmission pathways [49]. Similar to companion animals, MRSA colonizing livestock can act as a significant reservoir for drug-resistance genes. The transmission of these genes is a significant epidemiological concern, because of the possible share in acquiring MRSA that colonizes humans. The high diversification of LA-MRSA isolation rates and their genetic variants in animal farming environments is common and clearly seen in studies from different parts of the world.
Researchers suggest that the current spread of LA-MRSA in Europe is connected to the international pig market [50]. What is more, the prevalence of LA-MRSA in pigs is rising constantly, with ST398 LA-MRSA lineage domination observed in most European countries [51,52]. Despite this, the epidemiological situation in other parts of the world differs. The domination of certain lineages of LA-MRSA in livestock farming environments is being observed (Table 2). The distribution of MRSA sequence types among livestock depends not only on geographical location [53,54] but also the major clonal lineages causing infections in humans, e.g., in Australian piggeries, as many as 84% of MRSA strains were classified as ST93—the most common CA-MRSA in the country. Additionally, MRSA isolation rates were high and accounted for 76% in animals and 60% in pig farm workers [55].
Staphylococcus aureus remains a major etiological factor of bovine mastitis [67,68], and it is estimated that methicillin-resistant strains are responsible for approximately 12% of infections [69,70]. Recent findings confirm that MRSA strains circulating among humans are capable of causing infection in cows [71]. Juhász-Kaszanyitzky et al. found that subclinical mastitis in cows on a Hungarian farm was caused by MRSA genetically undistinguishable from a strain isolated from a farm worker. Moreover, an alarmingly high percentage of MRSA strains isolated from dairy cows harbor multiple enterotoxin genes simultaneously (seg, sei, sem, sen, seo, and seu), making a possible outbreak from contaminated milk more health-threatening to humans [61].
Methicillin-resistant strains are also present in poultry [49,57,58,72] and poultry-derived products [73,74]. In some countries, the prevalence of MRSA among poultry has been found to be relatively high. In Algeria, as many as 57% of laying hens and 50% of broiler chickens were found to be colonized with MRSA. The authors also found that the poultry were significantly more often colonized than the bovine animals (31%), [49]. The poultry were found to be colonized not only by livestock-associated CC398 but also by strains of human origin [58]; thus, the epidemiological situation regarding poultry market should be carefully monitored in order to limit the spread of virulent MRSA strains in the environment.
In comparison to the environment of large-scale farms with bovine, swine or poultry, the epidemiology of S. aureus differs in small dairy-ruminant herds. Carfora et al. observed low intra-farm prevalence of both MSSA and MRSA among sheep. In total, 2.16% of milk samples were found S. aureus positive and only 0.34% MRSA positive, however, genotyping revealed that all MRSA collected from animals and farm workers belonged to the same MLST variant (ST1), [75]. MRSA is also being isolated from goats. Loncaric et al. described a case of necropsy in a goat caused by LA-MRSA ST398. The same strain was isolated earlier from the goat’s owner, proving the infectious potential of LA-MRSA transmitted from the human host to the animal [76]. In the Czech Republic, LA-MRSA ST398 was isolated on a goat farm, both from animals and personnel, indicating circulation of S. aureus in a given environment; however, the authors did not detect any MRSA strains among sheep and pig farms in the same homestead [62]. The presence of MRSA was also found in rabbits; S. aureus was detected both as a colonizing agent as well as an etiological factor causing lesions. Large-scale studies in commercial rabbitries located on the Iberian Peninsula revealed the presence of MRSA in 19 out of 89 farms with an 11.25% colonization rate among rabbits [63].
The presence of MRSA in the large-scale farming environment challenges current epidemiological approaches limiting the circulation of pathogens between animals and humans. Moreover, it increases the probability of the emergence of new pathogenic microorganisms, making agro-ecosystems a global threat to public health.

4. Transmission of Animal-Associated Staphylococcus aureus between Animals and Humans

Transmission of pathogens between animals and humans has been occurring since humans develop farming practices that made them stay in close contact with animals. Current epidemiological studies report a growing rate of infections in humans caused by pathogens of animal origin. In the last decade, the main methicillin-resistant livestock-associated clonal lineage, ST398, has been isolated more recently from humans. Its presence has been detected in colonized individuals having direct contact not only with farming environments but also in nosocomial environments, where it is an etiological factor of a wide range of infections. The alarming emergence of ST398 in hospitals can further ease its spread and thus help it to persist in the human population as an effect of human-host adaptation [77]. Recently, the presence of human-adapted ST398 MRSA strains in clinical samples in Taiwan has been reported [78]. What is important is that ST398’s emergence as an etiological factor of human infections in Europe results from the intensive export of pigs from countries with a high ST398 burden in the farming environment, e.g., the Netherlands [50].
Large-scale survey studies that made a collection of data available reflecting the current epidemiological situation concerning the dynamic of the spread of livestock-associated MRSA strains among humans revealed increasing trends in LA-MRSA isolation rates from human clinical samples. Livestock-associated strains of MRSA were detected among humans in 17 out of 19 EU countries, with the highest LA-MRSA prevalence rates noted for the Netherlands (30.7%), Denmark (29.3%), and Spain (9.7%), [79]. The prevalently found bovine strains CC97 is considered as an emerging etiological factor of human infection. This observation is confirmed by a statistically significant increase in the share of CC97 among S. aureus isolated from human infections in Denmark over a five-year period (from 0.3% in the year 2007 to 1.7% in 2011), [80]. Although we did not find any research covering the same topic that is more recent, this study demonstrates an important trend concerning CC97 epidemiology. Other authors estimated the LA-MRSA burden among the human population in Eastern England classifying the prevalence of LA-MRSA among MRSA-infected patients as low (less than 1%), [16]. Although most of the studies mentioned investigated the occurrence of LA-MRSA among humans in European countries, these strains have also been isolated in the US [66,81], Canada [82], China [78,83], and India [84].
Whereas advanced genotyping methods allow for the genetic comparison of S. aureus of human and animal origin, it is still difficult to undeniably prove the source of MRSA and the direction of its transmission [71]; thus, studies should cover longer periods of time along with repeated sampling [46,85]. The Denmark region has one of the most thoroughly investigated epidemiological situations concerning LA-MRSA strains [86,87]. Studies revealed that in Denmark, the increased prevalence of MRSA colonization and infection rates among pigs as well as humans was caused by the clonal spread of only a few lineages of CC398. Moreover, moving animals from farm to farm remained the main route of MRSA transmission [88]. An alarming situation might be found in countries where pigs are considered to be the main reservoir for MRSA, which in addition to a low prevalence of MRSA of human origin in the nosocomial environment creates a substantial epidemiological problem concerning the transfer of MRSA from livestock to the general community. Additionally, many authors have proven that people working in a farming environment are at higher risk of livestock-associated CC398 colonization [56].
The role of wild animals in intra- and interfarm MRSA transmission is a matter rarely discussed [89]. Methicillin-resistant S. aureus strains have already been detected in multiple species of wild animals, e.g., boars, deers, hares, or hedgehogs [90,91,92,93,94]. Despite the wide genetic diversity of isolated MRSA, typical LA-MRSA strains like ST398 have also been detected. A recent study indicated the possibility of MRSA transmission on a Canadian pig farm via colonized Norway rats. In spite of the fact that the prevalence rates of MRSA colonization in rats are currently classified as low, this route of MRSA dissemination should be considered in large-scale epidemiological studies [95,96].
The transmission of MRSA between species might also occur indirectly—via contaminated air and dust particles [97]. Locatelli et al. noticed the presence of the same genetic variants of LA-MRSA among dairy cattle, swine, farm workers, and dust samples, suggesting the wide strain dissemination in the environment and indicating the complexity of its transmission as well as great potential for zoonotic transmission [60]. A Danish study concerning airborne MRSA on pig farms revealed that MRSA was present in particles of different sizes enabling inhalation and deposition not only in the human upper airways but also in the bronchi and the alveoli. The authors found that 21.5% of S. aureus present in the air was able to deposit in the primary and secondary bronchi [98]. The airborne colonization models proved that the concentration of airborne MRSA significantly influences the percentage of MRSA-positive environmental swab samples. What is more, the concentration of MRSA in the air affects the duration of colonization among piglets. A recent study showed that, dependent on the MRSA concentration, animals were colonized permanently (106 CFU/m3), transiently (104 CFU/m3), or non-colonized (102 CFU/m3), [99].
The complexity of human–animal interactions as well as the abundance of transmission routes not only intensify MRSA circulation but also make an epidemiological investigation a lot more demanding and require the use of advanced genotyping methods.

5. Host-Adaptation Mechanisms

One of the greatest concerns of modern epidemiology of infectious diseases is the ability of animal pathogens to adapt to the human host. Many studies had proven that S. aureus is a multi-host bacterial pathogen; however, the mechanisms thanks to which this bacterium achieved this ecological success are rarely studied. S. aureus strains usually harbor a specific pool of genes, allowing for host-adaptation; however, only a few combinations provide a universal package, providing the capacity to colonize and infect multiple host species [100]. Although various MRSA clonal complexes are being isolated from large-scale animal farming environments, only a few of them seem to have an ability to spread and persist among animal populations. A large-scale study concerning MRSA epidemiology on Norwegian farms proved that MRSA variants within CC1 had the ability to adapt and persist in a swine population for longer periods of time, which is connected with the changing epidemiology of LA-MRSA [101]. Researchers also investigated the capability of MRSA strains of human origin commonly colonizing animals to readapt back to human host. Everyday contact between companion animals and their owners might trigger readaptation leading to the spread of MRSA strains among humans [25].
One of the main components of the S. aureus genome allowing for adaptation to the human host is the presence of the ΦSa3 phage encoding proteins responsible for the ability to avoid the response of the innate immune system. Researchers have observed that the human to livestock host jump of S. aureus is often connected to the loss of the above-mentioned genetic element [102]. Moreover, ΦSa3-positive variants of LA-MRSA strains have been reported in chicken meat products; thus, poultry meat might be a significant source of LA-MRSA strains in the community, posing a health threat to people without direct contact with the farming environment [103]. Novel data provide strong proof that LA-MRSA ST398 originally evolved from human strains and then established in animal populations along with the loss of ΦSa3 prophage carrying the human innate immunomodulatory genes (Figure 1). Primary methicillin and tetracycline-susceptible ST398 acquired resistance after host switch, which additionally, raises serious questions regarding the role of the selection of antibiotic-resistant strains as a result of the extensive use of antibiotics in animal production [104]. Currently, one of the main features distinguishing LA-MRSA CC398, from CA- and HA-MRSA strains of human origin is that animal-associated clones often harbor the tet(M) gene and are therefore resistant to tetracyclines [25,105].
The presence of staphylococcal pathogenicity islands might also be involved in a host range of various clonal lineages of MRSA. This mobile structure contains important virulence factors enabling colonization and infection within different types of tissue [106]. For example, novel pathogenicity island SaPI-S0385 encodes extracellular factors like the von Willebrand factor binding protein and staphylococcal complement inhibitor that favor the development of infection in humans [107]. Although large genetic variations among MRSA lineages are common, strains exhibiting host-specific features have been observed [108]. Bacteriophage phi3 gene cluster encoding immune evasion proteins have been isolated more frequently in MRSA isolated from humans than from animals [109]; however, a recent longitudinal study downgraded its role as an evolutionary driver in the readaptation of AA-MRSA to human hosts [106]. Some studies revealed that certain genetic variants of the HA-MRSA USA300 lineage are able to persist within keratinocytes, simultaneously evading clearance and leading to skin infections in humans [110]. As mentioned above, the presence of certain genes connected with adaptation to human hosts has been investigated and described; however, the situation remains largely unknown when it comes to the animal adaptation of MRSA. Additionally, future large-scale studies should focus on determining the universal package of genes encoding proteins that provide adaptation to multiple hosts resulting in the evolutionary success of major clonal lineages of MRSA.
Studies relying on comprehensive phylogenetic analysis of AA-MRSA reveal novel insights about its host-adaptation mechanisms. Richardson et al. revealed that humans are a major donor of S. aureus to pigs, cows, sheep, goats, carnivores, birds, rabbits, horses, and rodents. Authors have also observed some interesting host-switching trends. Cows were considered as the most prevalent recipient for human S. aureus and the strains of sheep origin were less likely to spread to other animals [100]. Sakwińska et al. showed the patterns of one-directional host adaptation of S. aureus between farmers and dairy cows. Over one-third of S. aureus strains isolated from mastitis belonged to the widely recognized human complex CC8. The authors explained this unusual observation by progressing bovine adaptation of typically human S. aureus occurring in Switzerland and European regions located nearby. On the other hand, the low rate of bovine-to-human transmission in the same environment suggested the loss of genetic determinants, allowing for the colonization of humans [67]. Taking into account close genetic relationships between humans and monkeys (non-human primates), researchers investigated the possibility of S. aureus transmission between these two groups of mammals [46,111]. Senghore et al. proved that the direction of transmission from human to non-human primates (green monkeys) was occurring more frequently. Moreover, WGS of isolates of human and monkey origin showed that the human-to-monkey host switch occurred nearly 3000 years ago and relied on the loss of genes allowing for human colonization [111].
Although livestock-to-human host shifts rarely occur, they might have an important meaning for public health. Some authors proved that a few of the LA-MRSA strains were not only able to switch hosts and spread among humans but were found as pandemic etiological factors of infection among people [80]. The line between human and animal-associated MRSA is consecutively blurring as an effect of the continuous and intense circulation of MRSA in the environment. For that reason, efforts should be made to limit the possible transmission pathways between humans and animals by implementing successful control and prevention programs.

6. Control Strategies and Monitoring Programs

The most effective action limiting the spread of zoonotic diseases is the implementation of strategies controlling their spread as well as creating successful programs enabling control of the current epidemiological situation. The prevalence of MRSA infection rates is rising both in livestock as well as in the general community along with the changes in the pathways and dynamics of MRSA transmission being observed on a global scale [112,113]. The spread of MRSA strains from animal farms to the general community might lead to an increase in colonization, carriage, and infection rates among humans. To limit the circulation of LA-MRSA between farms and the community, many programs have been established and strategies applied, some of them successful [112]. The influence of short-term contact with the animal farming environment on subsequent colonization and its duration among humans is being discussed. Angen et al. found that the nasal carriage of LA-MRSA was positively correlated with short-time exposure to MRSA present in the air as well as with active work on a swine farm. Despite the fact that 94% of people were MRSA-positive in their nasal cavity directly after exposure, colonization was classified as intermittent and lasted up to 48 h only [112]. The results suggest that reducing the time spent in direct contact with livestock animals and their environment can significantly limit the risk of AA-MRSA transmission to humans. Some authors suggest that a safe distance between farms might be a successful biosecurity strategy limiting the circulation of LA-MRSA between different animal species [60]. Another strategy that can be implemented in order to avoid the spread of AA-MRSA to humans is the active decolonization of farm workers, which is a part of the most unique and complex MRSA control strategy in swine farms applied in Norway. The program consists of routine annual screening of the swine population, followed by a more detailed examination with the implementation of control measures and eradication in the case of LA-MRSA detection, both among animals as well as farm workers [101]. Other strategies consist of actions preventing MRSA introduction into farms. Researchers suggest that the combination of multiple biosecurity protocols can efficiently limit the transmission of MRSA, e.g., disinfection of transport vehicles, purchase of MRSA-negative herds of animals, temporary quarantine of new herds, or limitations concerning farm workers, like showers before and after visiting farms or wearing gloves [114].
Except for the direct isolation of MRSA from animals, it is often detected in the environment, especially farm dust. Dust particles suspended in the air ease the deposition of LA-MRSA in the nasal cavity of animals and workers enabling its transmission. The role of this factor in LA-MRSA dissemination can be limited by applying efficient ventilation along with air filtration. On the other hand, high-pressure cleaning and intensive air movements lead to a rapid increase in airborne MRSA making the use of personal dust masks indispensable [98]. Studies have proven that airborne MRSA acquisition can be successfully reduced by wearing protective masks—only 9% of the participants wearing masks were LA-MRSA positive in their nasal cavity when compared to as much as 63% of unprotected short-term visitors [115]. These simple protection activities can significantly limit LA-MRSA circulation and transmission between humans and animals as well as reduce MRSA colonization rates. Additionally, the implementation of programs controlling the use of antibiotics can limit the emergence of new MRSA strains of animal origin in the large-scale farming environment [116]. Because studies have revealed that humans are the donors of the currently dominating MRSA strains in farming environments, efforts should be made to limit the contact of animals with humans, as well as the overlapping of living habitats of animals and humans. What is important is that such activities might have a positive effect both for animals and humans. Moreover, taking into account the intensive export and import of animals, especially pigs, international monitoring programs should be applied to gain detailed knowledge of the current epidemiological situation.
Except for standard procedures limiting the spread of MRSA in the environment, there are multiple interesting alternatives, including the application of probiotics, mainly lactic acid bacteria such as Lactobacillus spp., to reduce the MRSA colonization load in animals, or therapies using bacteriophages in the treatment of staphylococcal infections [114]. Although these strategies are promising, more comprehensive clinical studies are needed to evaluate their usefulness in vivo.
Although current research focuses mainly on the development of programs aiming at limiting the spread of MRSA in farming environments, the transmission of MRSA between owners and pets remains a significant matter, especially for immunocompromised people. Currently, the best practices recommended that might decrease the risk of MRSA transmission include maintaining basic hygienic activities in households with pets, washing hands before and after contact with an animal, or excluding access to certain spaces, e.g., the bedroom [117].

7. Conclusions

The transmission of AA-MRSA strains among livestock and farmers occurs via direct contact between animals and people as well as indirect contact with farm dust or contaminated equipment. Because multiple studies have detected the presence of the same genetic variants of AA-MRSA simultaneously in animals, farm workers, environmental samples, meat products, and milk (LA-MRSA has been isolated from a variety of sources), the determination of the direction of transmission is difficult; thus, researchers should focus more on the persistence of MRSA carriage and colonization and infection patterns. Most of the studies proved that S. aureus strains colonizing animals rarely infect humans. Nevertheless, AA-MRSA strains undergo host-adaptive evolution allowing them to spread and persist among human populations. Therefore, strategies to reduce the risk of emerging new pathogens of zoonotic origin should rely on surveillance conducted worldwide followed by the implementation of protocols as well as biosecurity measures limiting the spread of AA-MRSA in the livestock and community environment.

Author Contributions

Conceptualization, M.K., Ł.W. and A.M.; writing—original draft preparation, M.O., K.I., E.D. and M.K.; writing—review and editing, Ł.W. and A.M.; visualization, M.O., K.I. and E.D.; supervision, M.K., Ł.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Spiliopoulou, I.; Petinaki, E. Methicillin-resistant Staphylococcus aureus colonization and infection risks from companion animals: Current perspectives. VMRR 2015, 6, 373–382. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Weese, J.S. Methicillin-resistant Staphylococcus aureus in animals. ILAR J. 2010, 51, 233–244. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Harkins, C.P.; Pichon, B.; Doumith, M.; Parkhill, J.; Westh, H.; Tomasz, A.; de Lencastre, H.; Bentley, S.D.; Kearns, A.M.; Holden, M.T.G. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol. 2017, 18, 130. [Google Scholar] [CrossRef] [Green Version]
  4. Armin, S.; Fallah, F.; Karimi, A.; Shirvani, F.; Azimi, L.; Tehrani, N.A.; Abdollahi, N.; Mobasseri, P.; Rajabnejad, M.; Ghanaiee, R.M.; et al. Prevalence and antimicrobial resistance patterns in ESKAPE pathogens in Iran. Arch. Pediatr. Infect. Dis. 2023, 11, e129629. [Google Scholar] [CrossRef]
  5. Liu, J.; Chen, D.; Peters, B.M.; Li, L.; Li, B.; Xu, Z.; Shirliff, M.E. Staphylococcal chromosomal cassettes mec (SCCmec): A mobile genetic element in methicillin-resistant Staphylococcus aureus. Microb. Pathog. 2016, 101, 56–67. [Google Scholar] [CrossRef]
  6. El Dessouky, Y.; Mouftah, S.; Elhadidy, M. Genomic overview into the evolving epidemiology of methicillin-resistant Staphylococcus aureus. Mansoura Vet. Med. J. 2020, 21, 125–131. [Google Scholar] [CrossRef]
  7. Silva, V.; Monteiro, A.; Pereira, J.E.; Maltez, L.; Igrejas, G.; Poeta, P. MRSA in humans, pets and livestock in Portugal: Where we came from and where we are going. Pathogens 2022, 11, 1110. [Google Scholar] [CrossRef]
  8. Nandhini, P.; Kumar, P.; Mickymaray, S.; Alothaim, A.S.; Somasundaram, J.; Rajan, M. Recent developments in methicillin-resistant Staphylococcus aureus (MRSA) treatment: A review. Antibiotics 2022, 11, 606. [Google Scholar] [CrossRef]
  9. Wu, Q.; Sabokroo, N.; Wang, Y.; Hashemian, M.; Karamollahi, S.; Kouhsari, E. Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates. Antimicrob. Resist. Infect. Control. 2021, 10, 101. [Google Scholar] [CrossRef]
  10. Guo, Y.; Song, G.; Sun, M.; Wang, J.; Wang, Y. Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front. Cell. Infect. Microbiol. 2020, 10, 107. [Google Scholar] [CrossRef] [Green Version]
  11. Liu, W.-T.; Chen, E.-Z.; Yang, L.; Peng, C.; Wang, Q.; Xu, Z.; Chen, D.-Q. Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review. Microb. Pathog. 2021, 156, 104915. [Google Scholar] [CrossRef]
  12. Bengtsson-Palme, J.; Kristiansson, E.; Larsson, D.G.J. Environmental Factors Influencing the Development and Spread of Antibiotic Resistance. FEMS Microbiol. Rev. 2018, 42, fux053. [Google Scholar] [CrossRef] [PubMed]
  13. Khairullah, A.R.; Sudjarwo, S.A.; Effendi, M.H.; Ramandinianto, S.C.; Gelolodo, M.A.; Widodo, A.; Riwu, K.H.P.; Kurniawati, D.A. Pet animals as reservoirs for spreading methicillin-resistant Staphylococcus aureus to human health. J. Adv. Vet. Anim. Res. 2023, 10, 1–13. [Google Scholar] [CrossRef]
  14. Aires-de-Sousa, M. Methicillin-resistant Staphylococcus aureus among animals: Current overview. Clin. Microbiol. Infect. 2017, 23, 373–380. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. European Medicines Agency. Reflection Paper on the Risk of Antimicrobial Resistance Transfer from Companion Animals. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-risk-antimicrobial-resistance-transfer-companion-animals_en.pdf (accessed on 28 May 2023).
  16. Harrison, E.M.; Coll, F.; Toleman, M.S.; Blane, B.; Brown, N.M.; Török, M.E.; Parkhill, J.; Peacock, S.J. Genomic surveillance reveals low prevalence of livestock-associated methicillin-resistant Staphylococcus aureus in the east of England. Sci. Rep. 2017, 7, 7406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Miao, J.; Chen, L.; Wang, J.; Wang, W.; Chen, D.; Li, L.; Li, B.; Deng, Y.; Xu, Z. Current methodologies on genotyping for nosocomial pathogen methicillin-resistant Staphylococcus aureus (MRSA). Microb. Pathog. 2017, 107, 17–28. [Google Scholar] [CrossRef] [PubMed]
  18. Misic, A.M.; Davis, M.F.; Tyldsley, A.S.; Hodkinson, B.P.; Tolomeo, P.; Hu, B.; Nachamkin, I.; Lautenbach, E.; Morris, D.O.; Grice, E.A. The shared microbiota of humans and companion animals as evaluated from Staphylococcus carriage sites. Microbiome 2015, 3, 2. [Google Scholar] [CrossRef] [Green Version]
  19. Davis, M.F.; Iverson, S.A.; Baron, P.; Vasse, A.; Silbergeld, E.K.; Lautenbach, E.; Morris, D.O. Household transmission of meticillin-resistant Staphylococcus aureus and other staphylococci. Lancet Infect. Dis. 2012, 12, 703–716. [Google Scholar] [CrossRef]
  20. Bramble, M.; Morris, D.; Tolomeo, P.; Lautenbach, E. Potential role of pet animals in household transmission of methicillin-resistant Staphylococcus aureus: A narrative review. Vector Borne Zoonotic Dis. 2011, 11, 617–620. [Google Scholar] [CrossRef] [Green Version]
  21. Bierowiec, K.; Płoneczka-Janeczko, K.; Rypuła, K. Is the colonisation of Staphylococcus aureus in pets associated with their close contact with owners? PLoS ONE 2016, 11, e0156052. [Google Scholar] [CrossRef] [Green Version]
  22. Asanin, J.; Misic, D.; Aksentijevic, K.; Tambur, Z.; Rakonjac, B.; Kovacevic, I.; Spergser, J.; Loncaric, I. Genetic profiling and comparison of human and animal methicillin-resistant Staphylococcus aureus (MRSA) isolates from Serbia. Antibiotics 2019, 8, 26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Daley, P.; Bajgai, J.; Penney, C.; Williams, K.; Whitney, H.; Golding, G.R.; Weese, S. A cross sectional study of animal and human colonization with methicillin-resistant Staphylococcus aureus (MRSA) in an aboriginal community. BMC Public Health 2016, 16, 595. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Findik, A.; ÇiFtci, A.; Önyay, T.; Sezener, M.G.; Koçak, Y.; Gülhan, T. Determination of methicillin resistance and some genotypic characteristics of staphylococci isolated from dogs and their owners. Turk. J. Vet. Anim. Sci. 2018, 42, 549–555. [Google Scholar] [CrossRef]
  25. Haenni, M.; Châtre, P.; Dupieux-Chabert, C.; Métayer, V.; Bes, M.; Madec, J.-Y.; Laurent, F. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in horses, cats, and dogs over a 5-year period in France. Front. Microbiol. 2017, 8, 2493. [Google Scholar] [CrossRef] [PubMed]
  26. van Duijkeren, E.; Wolfhagen, M.J.H.M.; Heck, M.E.O.C.; Wannet, W.J.B. Transmission of a panton-valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J. Clin. Microbiol. 2005, 43, 6209–6211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Weese, J.S.; Dick, H.; Willey, B.M.; McGeer, A.; Kreiswirth, B.N.; Innis, B.; Low, D.E. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet. Microbiol. 2006, 115, 148–155. [Google Scholar] [CrossRef] [PubMed]
  28. Hemeg, H.A. Determination of phylogenetic relationships among methicillin-resistant Staphylococcus aureus recovered from infected humans and companion animals. Saudi J. Biol. Sci. 2021, 28, 2098–2101. [Google Scholar] [CrossRef]
  29. Rynhoud, H.; Forde, B.M.; Beatson, S.A.; Abraham, S.; Meler, E.; Soares Magalhães, R.J.; Gibson, J.S. Molecular epidemiology of clinical and colonizing methicillin-resistant Staphylococcus isolates in companion animals. Front. Vet. Sci. 2021, 8, 620491. [Google Scholar] [CrossRef]
  30. Walther, B.; Wieler, L.H.; Friedrich, A.W.; Hanssen, A.-M.; Kohn, B.; Brunnberg, L.; Lübke-Becker, A. Methicillin-resistant Staphylococcus aureus (MRSA) isolated from small and exotic animals at a university hospital during routine microbiological examinations. Vet. Microbiol. 2008, 127, 171–178. [Google Scholar] [CrossRef]
  31. Ferreira, J.P.; Fowler, V.G.; Correa, M.T.; Lyman, R.; Ruffin, F.; Anderson, K.L. Transmission of methicillin-resistant Staphylococcus aureus between human and hamster. J. Clin. Microbiol. 2011, 49, 1679–1680. [Google Scholar] [CrossRef] [Green Version]
  32. Strommenger, B.; Kehrenberg, C.; Kettlitz, C.; Cuny, C.; Verspohl, J.; Witte, W.; Schwarz, S. Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J. Antimicrob. Chemother. 2006, 57, 461–465. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Drougka, E.; Foka, A.; Koutinas, C.K.; Jelastopulu, E.; Giormezis, N.; Farmaki, O.; Sarrou, S.; Anastassiou, E.D.; Petinaki, E.; Spiliopoulou, I. Interspecies spread of Staphylococcus aureus clones among companion animals and human close contacts in a veterinary teaching hospital. A cross-sectional study in Greece. Prev. Vet. Med. 2016, 126, 190–198. [Google Scholar] [CrossRef] [PubMed]
  34. Vincze, S.; Stamm, I.; Kopp, P.A.; Hermes, J.; Adlhoch, C.; Semmler, T.; Wieler, L.H.; Lübke-Becker, A.; Walther, B. Alarming proportions of methicillin-resistant Staphylococcus aureus (MRSA) in wound samples from companion animals, Germany 2010–2012. PLoS ONE 2014, 9, e85656. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Loeffler, A.; Pfeiffer, D.U.; Lindsay, J.A.; Magalhães, R.J.S.; Lloyd, D.H. Prevalence of and risk factors for MRSA carriage in companion animals: A survey of dogs, cats and horses. Epidemiol. Infect. 2011, 139, 1019–1028. [Google Scholar] [CrossRef] [Green Version]
  36. Kittl, S.; Brodard, I.; Heim, D.; Andina-Pfister, P.; Overesch, G. Methicillin-resistant Staphylococcus aureus dtrains in swiss pigs and their relation to isolates from farmers and veterinarians. Appl. Environ. Microbiol. 2020, 86, e01865-19. [Google Scholar] [CrossRef]
  37. Albert, E.; Sahin-Tóth, J.; Horváth, A.; Papp, M.; Biksi, I.; Dobay, O. Genomic evidence for direct transmission of mecC-MRSA between a horse and its veterinarian. Antibiotics 2023, 12, 408. [Google Scholar] [CrossRef] [PubMed]
  38. Costa, S.S.; Ribeiro, R.; Serrano, M.; Oliveira, K.; Ferreira, C.; Leal, M.; Pomba, C.; Couto, I. Staphylococcus aureus causing skin and soft tissue infections in companion animals: Antimicrobial resistance profiles and clonal lineages. Antibiotics 2022, 11, 599. [Google Scholar] [CrossRef]
  39. Quitoco, I.M.Z.; Ramundo, M.S.; Silva-Carvalho, M.C.; Souza, R.R.; Beltrame, C.O.; de Oliveira, T.F.; Araújo, R.; Del Peloso, P.F.; Coelho, L.R.; Figueiredo, A.M.S. First report in South America of companion animal colonization by the USA1100 clone of community-acquired meticillin-resistant Staphylococcus aureus (ST30) and by the european clone of methicillin-resistant Staphylococcus pseudintermedius (ST71). BMC Res. Notes 2013, 6, 336. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Penna, B.; Silva, M.B.; Soares, A.E.R.; Vasconcelos, A.T.R.; Ramundo, M.S.; Ferreira, F.A.; Silva-Carvalho, M.C.; de Sousa, V.S.; Rabello, R.F.; Bandeira, P.T.; et al. Comparative genomics of MRSA strains from human and canine origins reveals similar virulence gene repertoire. Sci. Rep. 2021, 11, 4724. [Google Scholar] [CrossRef] [PubMed]
  41. Taniguchi, Y.; Koide, S.; Maeyama, Y.; Tamai, K.; Hayashi, W.; Tanaka, H.; Iimura, M.; Suzuki, M.; Nagano, Y.; Arakawa, Y.; et al. Predominance of methicillin-resistant Staphylococcus aureus SCCmec Type II-CC5 and SCCmec Type IV-CC1/CC8 among companion animal clinical isolates in Japan: Findings from phylogenetic comparison with human clinical isolates. J. Glob. Antimicrob. Resist. 2020, 20, 253–259. [Google Scholar] [CrossRef]
  42. Ma, G.C.; Worthing, K.A.; Ward, M.P.; Norris, J.M. Commensal staphylococci including methicillin-resistant Staphylococcus aureus from dogs and cats in remote New South Wales, Australia. Microb. Ecol. 2020, 79, 164–174. [Google Scholar] [CrossRef] [PubMed]
  43. Chueahiran, S.; Yindee, J.; Boonkham, P.; Suanpairintr, N.; Chanchaithong, P. Methicillin-resistant Staphylococcus aureus clonal complex 398 as a major MRSA lineage in dogs and cats in Thailand. Antibiotics 2021, 10, 243. [Google Scholar] [CrossRef] [PubMed]
  44. Aklilu, E.; Zunita, Z.; Hassan, L.; Chen, H.C. Phenotypic and genotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolated from dogs and cats at University Veterinary Hospital, Universiti Putra Malaysia. Trop. Biomed. 2010, 27, 483–492. [Google Scholar] [PubMed]
  45. Youn, J.-H.; Park, Y.H.; Hang’ombe, B.; Sugimoto, C. Prevalence and characterization of Staphylococcus aureus and Staphylococcus pseudintermedius isolated from companion animals and environment in the Veterinary Teaching Hospital in Zambia, Africa. Comp. Immunol. Microbiol. Infect. Dis. 2014, 37, 123–130. [Google Scholar] [CrossRef]
  46. Schaumburg, F.; Pauly, M.; Anoh, E.; Mossoun, A.; Wiersma, L.; Schubert, G.; Flammen, A.; Alabi, A.S.; Muyembe-Tamfum, J.-J.; Grobusch, M.P.; et al. Staphylococcus aureus complex from animals and humans in three remote African regions. Clin. Microbiol. Infect. 2015, 21, 345.e1–345.e8. [Google Scholar] [CrossRef] [Green Version]
  47. Shallcross, L.J.; Fragaszy, E.; Johnson, A.M.; Hayward, A.C. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: A systematic review and meta-analysis. Lancet Infect. Dis. 2013, 13, 43–54. [Google Scholar] [CrossRef] [Green Version]
  48. Adler, A.; Temper, V.; Block, C.S.; Abramson, N.; Moses, A.E. Panton-Valentine leukocidin–producing Staphylococcus aureus. Emerg. Infect. Dis. 2006, 12, 1789–1790. [Google Scholar] [CrossRef]
  49. Bounar-Kechih, S.; Hamdi, T.M.; Aggad, H.; Meguenni, N.; Cantekin, Z. Carriage methicillin-resistant Staphylococcus aureus in poultry and cattle in Northern Algeria. Vet. Med. Int. 2018, 2018, 4636121. [Google Scholar] [CrossRef] [Green Version]
  50. Krziwanek, K.; Metz-Gercek, S.; Mittermayer, H. Methicillin-resistant Staphylococcus aureus ST398 from human patients, Upper Austria. Emerg. Infect. Dis. 2009, 15, 766–769. [Google Scholar] [CrossRef] [Green Version]
  51. Abreu, R.; Rodríguez-Álvarez, C.; Lecuona, M.; Castro, B.; González, J.C.; Aguirre-Jaime, A.; Arias, Á. Increased antimicrobial resistance of MRSA strains isolated from pigs in Spain between 2009 and 2018. Vet. Sci. 2019, 6, 38. [Google Scholar] [CrossRef] [Green Version]
  52. Crombé, F.; Argudín, M.A.; Vanderhaeghen, W.; Hermans, K.; Haesebrouck, F.; Butaye, P. Transmission dynamics of methicillin-resistant Staphylococcus aureus in pigs. Front. Microbiol. 2013, 4, 57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Sun, J.; Yang, M.; Sreevatsan, S.; Davies, P.R. Prevalence and characterization of Staphylococcus aureus in growing pigs in the USA. PLoS ONE 2015, 10, e0143670. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Li, S.-M.; Zhou, Y.-F.; Li, L.; Fang, L.-X.; Duan, J.-H.; Liu, F.-R.; Liang, H.-Q.; Wu, Y.-T.; Gu, W.-Q.; Liao, X.-P.; et al. Characterization of the multi-drug resistance gene cfr in methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from animals and humans in China. Front. Microbiol. 2018, 9, 2925. [Google Scholar] [CrossRef] [PubMed]
  55. Sahibzada, S.; Abraham, S.; Coombs, G.W.; Pang, S.; Hernández-Jover, M.; Jordan, D.; Heller, J. Transmission of highly virulent community-associated MRSA ST93 and livestock-associated MRSA ST398 between humans and pigs in Australia. Sci. Rep. 2017, 7, 5273. [Google Scholar] [CrossRef] [Green Version]
  56. Lewis, H.C.; Mølbak, K.; Reese, C.; Aarestrup, F.M.; Selchau, M.; Sørum, M.; Skov, R.L. Pigs as source of methicillin-resistant Staphylococcus aureus CC398 infections in humans, Denmark. Emerg. Infect. Dis. 2008, 14, 1383–1389. [Google Scholar] [CrossRef]
  57. van Duijkeren, E.; Hengeveld, P.; Zomer, T.P.; Landman, F.; Bosch, T.; Haenen, A.; van de Giessen, A. Transmission of MRSA between humans and animals on duck and turkey farms. J. Antimicrob. Chemother. 2016, 71, 58–62. [Google Scholar] [CrossRef] [Green Version]
  58. Nemeghaire, S.; Roelandt, S.; Argudín, M.A.; Haesebrouck, F.; Butaye, P. Characterization of methicillin-resistant Staphylococcus aureus from healthy carrier chickens. Avian Pathol. 2013, 42, 342–346. [Google Scholar] [CrossRef]
  59. Silva, V.; Vieira-Pinto, M.; Saraiva, C.; Manageiro, V.; Reis, L.; Ferreira, E.; Caniça, M.; Capelo, J.L.; Igrejas, G.; Poeta, P. Prevalence and characteristics of multidrug-resistant livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) CC398 isolated from quails (Coturnix Coturnix Japonica) slaughtered for human consumption. Animals 2021, 11, 2038. [Google Scholar] [CrossRef]
  60. Locatelli, C.; Cremonesi, P.; Caprioli, A.; Carfora, V.; Ianzano, A.; Barberio, A.; Morandi, S.; Casula, A.; Castiglioni, B.; Bronzo, V.; et al. Occurrence of methicillin-resistant Staphylococcus aureus in dairy cattle herds, related swine farms, and humans in contact with herds. J. Dairy Sci. 2017, 100, 608–619. [Google Scholar] [CrossRef] [Green Version]
  61. Magro, G.; Rebolini, M.; Beretta, D.; Piccinini, R. Methicillin-resistant Staphylococcus aureus CC22-MRSA-IV as an agent of dairy cow intramammary infections. Vet. Microbiol. 2018, 227, 29–33. [Google Scholar] [CrossRef]
  62. Klimešová, M.; Manga, I.; Nejeschlebová, L.; Horáček, J.; Ponížil, A.; Vondrušková, E. Occurrence of Staphylococcus aureus in cattle, sheep, goat, and pig rearing in the Czech Republic. Acta Vet. Brno 2017, 86, 3–10. [Google Scholar] [CrossRef] [Green Version]
  63. Moreno-Grúa, E.; Pérez-Fuentes, S.; Muñoz-Silvestre, A.; Viana, D.; Fernández-Ros, A.B.; Sanz-Tejero, C.; Corpa, J.M.; Selva, L. Characterization of livestock-associated methicillin-resistant Staphylococcus aureus isolates obtained from commercial rabbitrieslocated in the Iberian Peninsula. Front. Microbiol. 2018, 9, 1812. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Zou, G.; Matuszewska, M.; Jia, M.; Zhou, J.; Ba, X.; Duan, J.; Zhang, C.; Zhao, J.; Tao, M.; Fan, J.; et al. A survey of chinese pig farms and human healthcare isolates reveals separate human and animal methicillin-resistant Staphylococcus aureus populations. Adv. Sci. 2022, 9, 2103388. [Google Scholar] [CrossRef]
  65. Venkatvasan, R.; Antony, P.X.; Mukhopadhyay, H.K.; Jayalakshmi, V.; Vivek Srinivas, V.M.; Thanislass, J.; Stephen, S. Characterization of methicillin-resistant Staphylococcus aureus from goats and their relationship to goat handlers using multi-locus sequence typing (MLST). Small Rumin. Res. 2020, 186, 106097. [Google Scholar] [CrossRef]
  66. Smith, T.C.; Male, M.J.; Harper, A.L.; Kroeger, J.S.; Tinkler, G.P.; Moritz, E.D.; Capuano, A.W.; Herwaldt, L.A.; Diekema, D.J. Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in Midwestern U.S. swine and swine workers. PLoS ONE 2009, 4, e4258. [Google Scholar] [CrossRef] [Green Version]
  67. Sakwinska, O.; Morisset, D.; Madec, J.-Y.; Waldvogel, A.; Moreillon, P.; Haenni, M. Link between genotype and antimicrobial resistance in bovine mastitis-related Staphylococcus aureus strains, determined by comparing swiss and french isolates from the Rhône Valley. Appl. Environ. Microbiol. 2011, 77, 3428–3432. [Google Scholar] [CrossRef] [Green Version]
  68. Fluit, A.C. Livestock-associated Staphylococcus aureus. Clin. Microbiol. Infect. 2012, 18, 735–744. [Google Scholar] [CrossRef] [Green Version]
  69. Algammal, A.M.; Enany, M.E.; El-Tarabili, R.M.; Ghobashy, M.O.I.; Helmy, Y.A. Prevalence, Antimicrobial resistance profiles, virulence and enterotoxins-determinant genes of MRSA isolated from subclinical bovine mastitis in Egypt. Pathogens 2020, 9, 362. [Google Scholar] [CrossRef]
  70. Guimarães, F.F.; Manzi, M.P.; Joaquim, S.F.; Richini-Pereira, V.B.; Langoni, H. Short communication: Outbreak of methicillin-resistant Staphylococcus aureus (MRSA)—Associated mastitis in a closed dairy herd. J. Dairy Sci. 2017, 100, 726–730. [Google Scholar] [CrossRef] [Green Version]
  71. Juhász-Kaszanyitzky, É.; Jánosi, S.; Somogyi, P.; Dán, Á.; vanderGraaf van Bloois, L.; van Duijkeren, E.; Wagenaar, J.A. MRSA transmission between cows and humans. Emerg. Infect. Dis. 2007, 13, 630–632. [Google Scholar] [CrossRef]
  72. Persoons, D.; Van Hoorebeke, S.; Hermans, K.; Butaye, P.; de Kruif, A.; Haesebrouck, F.; Dewulf, J. Methicillin-resistant Staphylococcus aureus in poultry. Emerg. Infect. Dis. 2009, 15, 452–453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Abdalrahman, L.; Stanley, A.; Wells, H.; Fakhr, M. Isolation, virulence, and antimicrobial resistance of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin sensitive Staphylococcus aureus (MSSA) strains from Oklahoma retail poultry meats. Int. J. Environ. Res. Public Health 2015, 12, 6148–6161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Tang, Y.; Larsen, J.; Kjeldgaard, J.; Andersen, P.S.; Skov, R.; Ingmer, H. Methicillin-resistant and -susceptible Staphylococcus aureus from retail meat in Denmark. Int. J. Food Microbiol. 2017, 249, 72–76. [Google Scholar] [CrossRef] [PubMed]
  75. Carfora, V.; Giacinti, G.; Sagrafoli, D.; Marri, N.; Giangolini, G.; Alba, P.; Feltrin, F.; Sorbara, L.; Amoruso, R.; Caprioli, A.; et al. Methicillin-resistant and methicillin-susceptible Staphylococcus aureus in dairy sheep and in-contact humans: An intra-farm study. J. Dairy Sci. 2016, 99, 4251–4258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Loncaric, I.; Brunthaler, R.; Spergser, J. Suspected goat-to-human transmission of methicillin-resistant Staphylococcus aureus sequence type 398. J. Clin. Microbiol. 2013, 51, 1625–1626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Witte, W.; Strommenger, B.; Stanek, C.; Cuny, C. Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, central Europe. Emerg. Infect. Dis. 2007, 13, 255–258. [Google Scholar] [CrossRef] [PubMed]
  78. Huang, Y.-C.; Chen, C.-J. Detection and phylogeny of Staphylococcus aureus sequence type 398 in Taiwan. J. Biomed. Sci. 2020, 27, 15. [Google Scholar] [CrossRef] [Green Version]
  79. Kinross, P.; Petersen, A.; Skov, R.; Van Hauwermeiren, E.; Pantosti, A.; Laurent, F.; Voss, A.; Kluytmans, J.; Struelens, M.J.; Heuer, O.; et al. Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013. Eurosurveillance 2017, 22, 16-00696. [Google Scholar] [CrossRef] [Green Version]
  80. Spoor, L.E.; McAdam, P.R.; Weinert, L.A.; Rambaut, A.; Hasman, H.; Aarestrup, F.M.; Kearns, A.M.; Larsen, A.R.; Skov, R.L.; Fitzgerald, J.R. Livestock origin for a human pandemic clone of community-associated methicillin-resistant Staphylococcus aureus. mBio 2013, 4, e00356-13. [Google Scholar] [CrossRef] [Green Version]
  81. Smith, T.C. Livestock-associated Staphylococcus aureus: The United States experience. PLoS Pathog. 2015, 11, e1004564. [Google Scholar] [CrossRef]
  82. Golding, G.R.; Bryden, L.; Levett, P.N.; McDonald, R.R.; Wong, A.; Wylie, J.; Graham, M.R.; Tyler, S.; Van Domselaar, G.; Simor, A.E.; et al. Livestock-associated methicillin-resistant Staphylococcus aureus sequence type 398 in humans, Canada. Emerg. Infect. Dis. 2010, 16, 587–594. [Google Scholar] [CrossRef] [PubMed]
  83. Chen, C.-J.; Lauderdale, T.-L.Y.; Lu, C.-T.; Chuang, Y.-Y.; Yang, C.-C.; Wu, T.-S.; Lee, C.-Y.; Lu, M.-C.; Ko, W.-C.; Huang, Y.-C. Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans. J. Antimicrob. Chemother. 2018, 73, 33–40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Gopal, S.; Divya, K.C. Can methicillin-resistant Staphylococcus aureus prevalence from dairy cows in India act as potential risk for community-associated infections? A review. Vet. World 2017, 10, 311–318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Morris, D.O.; Lautenbach, E.; Zaoutis, T.; Leckerman, K.; Edelstein, P.H.; Rankin, S.C. Potential for pet animals to harbour methicillin-resistant Staphylococcus aureus when residing with human MRSA patients: Role of pets as reservoirs for MRSA. Zoonoses Public Health 2012, 59, 286–293. [Google Scholar] [CrossRef]
  86. Sørensen, A.I.V. Spread and Control of Livestock-Associated Methicillin-Resistant Staphylococcus aureus (LA-MRSA) in Danish Pig Herds. Ph.D. Thesis, DTU Veterinærinstituttet, Lyngby, Denmark, 2018. [Google Scholar]
  87. Larsen, J.; Petersen, A.; Larsen, A.R.; Sieber, R.N.; Stegger, M.; Koch, A.; Aarestrup, F.M.; Price, L.B.; Skov, R.L.; Danish MRSA Study Group. Emergence of livestock-associated methicillin-resistant Staphylococcus aureus bloodstream infections in Denmark. Clin. Infect. Dis. 2017, 65, 1072–1076. [Google Scholar] [CrossRef] [Green Version]
  88. Sieber, R.N.; Skov, R.L.; Nielsen, J.; Schulz, J.; Price, L.B.; Aarestrup, F.M.; Larsen, A.R.; Stegger, M.; Larsen, J. Drivers and dynamics of methicillin-resistant livestock-associated Staphylococcus aureus CC398 in pigs and humans in Denmark. mBio 2018, 9, e02142-18. [Google Scholar] [CrossRef] [Green Version]
  89. Silva, V.; Capelo, J.L.; Igrejas, G.; Poeta, P. Molecular epidemiology of Staphylococcus aureus lineages in wild animals in Europe: A review. Antibiotics 2020, 9, 122. [Google Scholar] [CrossRef] [Green Version]
  90. Silva, V.; Pereira, J.E.; Maltez, L.; Ferreira, E.; Manageiro, V.; Caniça, M.; Capelo, J.L.; Igrejas, G.; Poeta, P. Diversity of methicillin-resistant staphylococci among wild lepus granatensis: First detection of mecA-MRSA in hares. FEMS Microbiol. Ecol. 2020, 96, fiz204. [Google Scholar] [CrossRef]
  91. Bengtsson, B.; Persson, L.; Ekström, K.; Unnerstad, H.E.; Uhlhorn, H.; Börjesson, S. High occurrence of mecC-MRSA in wild hedgehogs (Erinaceus europaeus) in Sweden. Vet. Microbiol. 2017, 207, 103–107. [Google Scholar] [CrossRef]
  92. Meemken, D.; Blaha, T.; Hotzel, H.; Strommenger, B.; Klein, G.; Ehricht, R.; Monecke, S.; Kehrenberg, C. Genotypic and phenotypic characterization of Staphylococcus aureus isolates from wild boars. Appl. Environ. Microbiol. 2013, 79, 1739–1742. [Google Scholar] [CrossRef] [Green Version]
  93. Porrero, M.C.; Mentaberre, G.; Sánchez, S.; Fernández-Llario, P.; Casas-Díaz, E.; Mateos, A.; Vidal, D.; Lavín, S.; Fernández-Garayzábal, J.-F.; Domínguez, L. Carriage of Staphylococcus aureus by free-living wild animals in Spain. Appl. Environ. Microbiol. 2014, 80, 4865–4870. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Ribeiro, M.; Sousa, M.; Borges, V.; Gomes, J.P.; Duarte, S.; Isidro, J.; Vieira, L.; Torres, C.; Santos, H.; Capelo, J.L.; et al. Bioinformatics study of expression from genomes of epidemiologically related MRSA CC398 isolates from human and wild animal samples. J. Proteom. 2022, 268, 104714. [Google Scholar] [CrossRef] [PubMed]
  95. Rothenburger, J.L.; Rousseau, J.D.; Weese, J.S.; Jardine, C.M. Livestock-associated methicillin-resistant Staphylococcus aureus and Clostridium difficile in wild norway rats (Rattus norvegicus) from Ontario swine farms. Can. J. Vet. Res. 2018, 82, 66–69. [Google Scholar] [PubMed]
  96. Himsworth, C.G.; Miller, R.R.; Montoya, V.; Hoang, L.; Romney, M.G.; Al-Rawahi, G.N.; Kerr, T.; Jardine, C.M.; Patrick, D.M.; Tang, P.; et al. Carriage of methicillin-resistant Staphylococcus aureus by wild urban norway rats (Rattus norvegicus). PLoS ONE 2014, 9, e87983. [Google Scholar] [CrossRef]
  97. Zhao, Y.; Aarnink, A.J.A.; De Jong, M.C.M.; Groot Koerkamp, P.W.G. Airborne microorganisms from livestock production systems and their relation to dust. Crit. Rev. Environ. Sci. Technol. 2014, 44, 1071–1128. [Google Scholar] [CrossRef]
  98. Madsen, A.M.; Kurdi, I.; Feld, L.; Tendal, K. Airborne MRSA and total Staphylococcus aureus as associated with particles of different sizes on pig farms. Ann. Work. Expo. Health 2018, 62, 966–977. [Google Scholar] [CrossRef] [Green Version]
  99. Rosen, K.; Roesler, U.; Merle, R.; Friese, A. Persistent and transient airborne MRSA colonization of piglets in a newly established animal model. Front. Microbiol. 2018, 9, 1542. [Google Scholar] [CrossRef] [Green Version]
  100. Richardson, E.J.; Bacigalupe, R.; Harrison, E.M.; Weinert, L.A.; Lycett, S.; Vrieling, M.; Robb, K.; Hoskisson, P.A.; Holden, M.T.G.; Feil, E.J.; et al. Gene exchange drives the ecological success of a multi-host bacterial pathogen. Nat. Ecol. Evol. 2018, 2, 1468–1478. [Google Scholar] [CrossRef]
  101. Elstrøm, P.; Grøntvedt, C.A.; Gabrielsen, C.; Stegger, M.; Angen, Ø.; Åmdal, S.; Enger, H.; Urdahl, A.M.; Jore, S.; Steinbakk, M.; et al. Livestock-associated MRSA CC1 in Norway; introduction to pig farms, zoonotic transmission, and eradication. Front. Microbiol. 2019, 10, 139. [Google Scholar] [CrossRef] [Green Version]
  102. Price, J.R.; Cole, K.; Bexley, A.; Kostiou, V.; Eyre, D.W.; Golubchik, T.; Wilson, D.J.; Crook, D.W.; Walker, A.S.; Peto, T.E.A.; et al. Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: A longitudinal cohort study based on whole-genome sequencing. Lancet Infect. Dis. 2017, 17, 207–214. [Google Scholar] [CrossRef] [Green Version]
  103. Larsen, J.; Stegger, M.; Andersen, P.S.; Petersen, A.; Larsen, A.R.; Westh, H.; Agersø, Y.; Fetsch, A.; Kraushaar, B.; Käsbohrer, A.; et al. Evidence for human adaptation and foodborne transmission of livestock-associated methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 2016, 63, 1349–1352. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Price, L.B.; Stegger, M.; Hasman, H.; Aziz, M.; Larsen, J.; Andersen, P.S.; Pearson, T.; Waters, A.E.; Foster, J.T.; Schupp, J.; et al. Staphylococcus aureus CC398: Host adaptation and emergence of methicillin resistance in livestock. mBio 2012, 3, e00305-11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Ye, X.; Wang, X.; Fan, Y.; Peng, Y.; Li, L.; Li, S.; Huang, J.; Yao, Z.; Chen, S. Genotypic and phenotypic markers of livestock-associated methicillin-resistant Staphylococcus aureus CC9 in humans. Appl. Environ. Microbiol. 2016, 82, 3892–3899. [Google Scholar] [CrossRef] [Green Version]
  106. van Alen, S.; Ballhausen, B.; Kaspar, U.; Köck, R.; Becker, K. Prevalence and genomic structure of bacteriophage phi3 in human-derived livestock-associated methicillin-resistant Staphylococcus aureus isolates from 2000 to 2015. J. Clin. Microbiol. 2018, 56, e00140-18. [Google Scholar] [CrossRef] [Green Version]
  107. Novick, R.P.; Ram, G. Staphylococcal pathogenicity islands—Movers and shakers in the genomic firmament. Curr. Opin. Microbiol. 2017, 38, 197–204. [Google Scholar] [CrossRef]
  108. McCarthy, A.J.; Lindsay, J.A. Staphylococcus aureus innate immune evasion is lineage-specific: Abioinfomatics study. Infection, Genet. Evol. 2013, 19, 7–14. [Google Scholar] [CrossRef] [PubMed]
  109. van Wamel, W.J.B.; Rooijakkers, S.H.M.; Ruyken, M.; van Kessel, K.P.M.; van Strijp, J.A.G. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J. Bacteriol. 2006, 188, 1310–1315. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  110. Soong, G.; Paulino, F.; Wachtel, S.; Parker, D.; Wickersham, M.; Zhang, D.; Brown, A.; Lauren, C.; Dowd, M.; West, E.; et al. Methicillin-resistant Staphylococcus aureus adaptation to human keratinocytes. mBio 2015, 6, e00289-15. [Google Scholar] [CrossRef] [Green Version]
  111. Senghore, M.; Bayliss, S.C.; Kwambana-Adams, B.A.; Foster-Nyarko, E.; Manneh, J.; Dione, M.; Badji, H.; Ebruke, C.; Doughty, E.L.; Thorpe, H.A.; et al. Transmission of Staphylococcus aureus from humans to green monkeys in the Gambia as revealed by whole-genome sequencing. Appl. Environ. Microbiol. 2016, 82, 5910–5917. [Google Scholar] [CrossRef] [Green Version]
  112. Angen, Ø.; Feld, L.; Larsen, J.; Rostgaard, K.; Skov, R.; Madsen, A.M.; Larsen, A.R. Transmission of methicillin-resistant Staphylococcus aureus to human volunteers visiting a swine farm. Appl. Environ. Microbiol. 2017, 83, e01489-17. [Google Scholar] [CrossRef] [Green Version]
  113. Di Ruscio, F.; Guzzetta, G.; Bjørnholt, J.V.; Leegaard, T.M.; Moen, A.E.F.; Merler, S.; Freiesleben de Blasio, B. Quantifying the transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country. Proc. Natl. Acad. Sci. USA 2019, 116, 14599–14605. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Crespo-Piazuelo, D.; Lawlor, P.G. Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) prevalence in humans in close contact with animals and measures to reduce on-farm colonisation. Ir. Vet. J. 2021, 74, 21. [Google Scholar] [CrossRef] [PubMed]
  115. Angen, Ø.; Skade, L.; Urth, T.R.; Andersson, M.; Bækbo, P.; Larsen, A.R. Controlling transmission of MRSA to humans during short-term visits to swine farms using dust masks. Front. Microbiol. 2019, 9, 3361. [Google Scholar] [CrossRef]
  116. Fitzgerald, J.R. Livestock-associated Staphylococcus aureus: Origin, evolution and public health threat. Trends Microbiol. 2012, 20, 192–198. [Google Scholar] [CrossRef] [PubMed]
  117. Morris, D.O.; Loeffler, A.; Davis, M.F.; Guardabassi, L.; Weese, J.S. Recommendations for approaches to meticillin-resistant staphylococcal infections of small animals: Diagnosis, therapeutic considerations and preventative measures. Vet. Dermatol. 2017, 28, 304-e69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Antibiotics 12 01079 g001 550
Figure 1. The origin of the ST398 MRSA lineage in animals and the main mechanisms of its readaptation to human hosts. Animal-associated MSSA ST398 developed as a result of its transmission from humans to animals, which was followed by the gain of methicillin and tetracycline resistance induced by the presence of antibiotics in the large-scale farming environment. Then, MRSA ST398 stabilized in the animal population. Close contact between humans and animal farms led to the readaptation of MRSA ST398 back to the human host, which was enabled by the acquisition of the ΦSa3 prophage carrying the human innate immunomodulatory genes. MSSA—methicillin-susceptible Staphylococcus aureus; MRSA—methicillin-resistant S. aureus.
Figure 1. The origin of the ST398 MRSA lineage in animals and the main mechanisms of its readaptation to human hosts. Animal-associated MSSA ST398 developed as a result of its transmission from humans to animals, which was followed by the gain of methicillin and tetracycline resistance induced by the presence of antibiotics in the large-scale farming environment. Then, MRSA ST398 stabilized in the animal population. Close contact between humans and animal farms led to the readaptation of MRSA ST398 back to the human host, which was enabled by the acquisition of the ΦSa3 prophage carrying the human innate immunomodulatory genes. MSSA—methicillin-susceptible Staphylococcus aureus; MRSA—methicillin-resistant S. aureus.
Antibiotics 12 01079 g001
Table
Table 1. Metihicillin-resistant Staphylococcus aureus lineages isolated from pet animals.
Table 1. Metihicillin-resistant Staphylococcus aureus lineages isolated from pet animals.
CountryYears of IsolationAnimalsMLSTLiterature
Germany2003–2004Dogs and catsCC22 (ST22)[32]
2010–2012CC22, CC5, CC398, CC8[34]
England2007–2008DogsCC30 (ST36)[35]
CatsCC22
HorsesCC22, CC8 (ST239)
Switzerland2017HorseST338[36]
Hungary2017HorseST130[37]
France2010–2015DogsCC8, CC398, CC5, CC22, CC45, CC1, CC59[25]
CatsCC8, CC398, CC5, CC22, CC130
HorsesCC398, CC8, CC130, CC49
Serbia2016DogsCC239, CC45, CC5[22]
CatCC1
Portugal1999–2018DogsCC22 (ST22), CC1 (ST188, ST6565, ST1), CC8 (ST72, ST6566), CC5 (ST105, ST5, ST6535), CC398 (ST398)[38]
CatsCC22 (ST22), CC8 (ST72), CC97 (ST97), CC7 (ST7), CC15 (ST15), CC5 (ST5), CC398 (ST398)
RabbitsCC22 (ST22), CC121 (ST121), CC398 (ST398)
HorseST816
US2010Dogs, cats, and a hamsterCC5[31]
Brazil2010CatST30[39]
2010–2013DogsST1, ST5, ST30, ST239[40]
Japan2016–2018CatsST5, ST764, ST512, ST1863, ST1, ST2725, ST4775, ST4779, ST8, ST4224, ST4777[41]
DogsST72, ST4776, ST5, ST4778, ST2725, ST8, ST380
RabbitsST4768
Australia2019DogsST1, ST5, ST72, ST93[42]
Thailand2017–2020DogsST398, ST5926, ST6563[43]
CatsST398
Malaysia2007–2008DogsST59[44]
CatsST55
Zambia2012DogsST 152, ST398, ST15, ST1416[45]
Table
Table 2. Methicillin-resistant Staphylococcus aureus lineages isolated from livestock animals.
Table 2. Methicillin-resistant Staphylococcus aureus lineages isolated from livestock animals.
CountryYears of IsolationAnimalsMLSTLiterature
Denmark2004–2007PigsST398[56]
2013–2014Ducks and turkeys[57]
Belgium2011ChickensST398, ST239[58]
Switzerland2017PigsST398[36]
Spain2009–2010PigsST398[51]
2017–2018
Portugal2020QuailsST398, ST6831[59]
Italy2010PigsCC398, CC97[60]
2018Dairy cowsCC22[61]
Czech Republic2017GoatsST398[62]
Spain
and Portugal		2014–2017RabbitsST2855, ST146, ST398[63]
Australia2015PigsST398, ST93, ST30[55]
China2011–2016PigsST9, ST764[54]
ChickensST9
DucksST9, ST398
2017–2018PigsST9, ST3653-6356, ST1376, ST59, ST398[64]
India2020GoatsST772, ST22, ST368[65]
Africa (Cote d’Ivoire)2012GoatsST15, ST152, ST6, ST8, ST1472[46]
SheepST15, ST88, ST152, ST567, ST121
ChickenST152
USA2006PigsST398[66]
2013–2014ST9, ST398, ST2007, ST1, ST5[53]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kasela, M.; Ossowski, M.; Dzikoń, E.; Ignatiuk, K.; Wlazło, Ł.; Malm, A. The Epidemiology of Animal-Associated Methicillin-Resistant Staphylococcus aureus. Antibiotics 2023, 12, 1079. https://doi.org/10.3390/antibiotics12061079

AMA Style

Kasela M, Ossowski M, Dzikoń E, Ignatiuk K, Wlazło Ł, Malm A. The Epidemiology of Animal-Associated Methicillin-Resistant Staphylococcus aureus. Antibiotics. 2023; 12(6):1079. https://doi.org/10.3390/antibiotics12061079

Chicago/Turabian Style

Kasela, Martyna, Mateusz Ossowski, Ewelina Dzikoń, Katarzyna Ignatiuk, Łukasz Wlazło, and Anna Malm. 2023. "The Epidemiology of Animal-Associated Methicillin-Resistant Staphylococcus aureus" Antibiotics 12, no. 6: 1079. https://doi.org/10.3390/antibiotics12061079

APA Style

Kasela, M., Ossowski, M., Dzikoń, E., Ignatiuk, K., Wlazło, Ł., & Malm, A. (2023). The Epidemiology of Animal-Associated Methicillin-Resistant Staphylococcus aureus. Antibiotics, 12(6), 1079. https://doi.org/10.3390/antibiotics12061079

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop